Join to View Full Profile
530 East 74th StreetNew York, NY 10021
Dr. Yarmohammadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Vascular and Interventional Radiology, 2012 - 2013
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Radiology-Diagnostic, 2008 - 2012
Shiraz University of Medical SciencesClass of 1996
Certifications & Licensure
NY State Medical License 2013 - 2026
NJ State Medical License 2017 - 2025
OH State Medical License 2008 - 2012
PA State Medical License 2007 - 2008
American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- Delivering a Diuretic Into the Liver Artery Followed by Plugging up the Artery to Starve Out Liver Cancer Cells Start of enrollment: 2017 Apr 05
Publications & Presentations
PubMed
- Outcomes of Transarterial Hepatic Embolization versus Yttrium-90 Radioembolization for Treatment of Patients with Hepatocellular Carcinoma > 7 cm.Sam Y Son, Sara Velayati, Ken Zhao, Brett Marinelli, Ruben Geevarghese
Journal of Vascular and Interventional Radiology. 2025-03-13 - Effectiveness and Safety of Peritoneovenous (Denver) Shunt Placement for Treatment of Chylous Ascites Following Unsuccessful Lymphatic Embolization.Anita Karimi, Amgad M Moussa, Vlasios S Sotirchos, Ernesto Santos, Sam Son
Journal of Vascular and Interventional Radiology. 2025-01-21 - TP53 Mutation Predicts Worse Survival and Earlier Local Progression in Patients with Hepatocellular Carcinoma Treated with Transarterial Embolization.Ken Zhao, Anita Karimi, Luke Kelly, Elena Petre, Brett Marinelli
Current Oncology. 2025-01-18
Authored Content
- Gene Signature Associated with Upregulation of the Wnt/Β-catenin Signaling Pathway Predicts Tumor Response to Transarterial EmbolizationMarch 2018
Press Mentions
Schedule at A GlanceJune 8th, 2015- SIO Requested Updates to NCCN GuidelinesJune 29th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
